AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample...
Ansh Labs, LLC began a recall of AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample DIL 1 x 100 mL, ENZ CONJ CONC 1 x 1.5 mL... on . FDA classified it as Class II and gives the reason as "Labeling update; To reduce the risk of false positive/false negative results the IFU for the adaptive immune response to SRS-CoV-2 testing is being updated to remove Plasma as a "sample type" and to update the...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.
Recall record
- Recall number
- Z-0842-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Ansh Labs, LLC
- Product
- AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample DIL 1 x 100 mL, ENZ CONJ CONC 1 x 1.5 mL, Calibrators A-C 3 x 1.2 mL, CONJ DIL 1 X 12 mL, Stop SOLN 1 X 12 mL, TMB SOLN 1 X 12 mL, WASH CONC A 1 X 60 mL, (01)00853592008219 - Product Usage: intended for the qualitative detection of IgM antibodies in serum collected from the individuals suspected with signs and symptoms of COVID-19 infection by their healthcare provider.
- Product code
- QKO Reagent, Coronavirus Serological
- Reason for recall
- Labeling update; To reduce the risk of false positive/false negative results the IFU for the adaptive immune response to SRS-CoV-2 testing is being updated to remove Plasma as a "sample type" and to update the "limitation" section to include potential cross-reactivity with non-SARS-CoV2 strains.
- Root cause tag
- design
- FDA root cause
- Device Design
- Action
- On 12/18/2020 and on 12/30/2020, Ansh Labs, sent a "Urgent: Medical Device Voluntary Correction" notification to all affected consignees via E-Mail. In addition to informing consignees about the recall, the firm asked consignees to take the following actions: 1. Previous versions of SARS-CoV2 IgM ELISA IFU.AL.1002 (Revision No.: 01 - 04) should be removed and discarded. The attached updated revision, SARS-CoV2 IgM ELISA IFU.AL.1002 (Revision No.: 05) should be used. 2. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. 3. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. 4. Please complete and return the attached Acknowledgement and Receipt Form within 10 days so we are assured you have received this important communication. 5. If you have any questions, please contact Ansh Labs at 281-404-0260, Monday through Friday 8:30 AM to 5:30 PM, Central Standard Time or at [email protected]. www.anshlabs.com
- Quantity in commerce
- 327 kits (93 test per kit)
- Distribution
- US Nationwide distribution including in the states of TX, MO, OK, MD, FL, NY, OR, GA, NC. OUS: None
- Product codes and lots
- Lot #/Expiration Date: 040720/2021-10-06, 041620/2021-10-15, 041720/2021-10-18, 042420/2021-10-15, 042720-A/2021-10-26
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0842-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
